Apathy in the older adult: Why you should care

Geriatrics

Volumn 59, Issue 7, 2004, Pages 34-36

  Orr, William B ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMANTADINE; AMFEBUTAMONE; AMPHETAMINE; ANTIDEPRESSANT AGENT; BROMOCRIPTINE; CENTRAL STIMULANT AGENT; CHOLINESTERASE INHIBITOR; DIGOXIN; DOPAMINE RECEPTOR STIMULATING AGENT; FUROSEMIDE; LONG ACTING DRUG; MEMANTINE; METFORMIN; METHYLPHENIDATE; MODAFINIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; SEROTONIN UPTAKE INHIBITOR;

AGED; ALZHEIMER DISEASE; APATHY; ATTITUDE; BEHAVIOR DISORDER; CAREGIVER; CASE REPORT; CLINICAL FEATURE; COGNITION; COGNITIVE DEFECT; COMORBIDITY; CONSCIOUSNESS DISORDER; DECISION MAKING; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG DOSE REGIMEN; DRUG TOLERABILITY; EMOTION; EMOTIONAL STRESS; FUNCTIONAL ASSESSMENT; GERIATRIC PATIENT; HUMAN; INTELLECTUAL IMPAIRMENT; IRRITABILITY; LOW DRUG DOSE; MALE; MENTAL DISEASE; MENTAL FUNCTION; MOTIVATION; OUTCOMES RESEARCH; PARKINSON DISEASE; PATIENT EDUCATION; PHYSICAL ACTIVITY; PSYCHOTHERAPY; REVIEW; SIDE EFFECT; SLEEP DISORDER; STROKE; SUPPORT GROUP; SYMPTOM; WEIGHT REDUCTION;

AGED; ANTIDEPRESSIVE AGENTS; CHOLINESTERASE INHIBITORS; COGNITION DISORDERS; DEPRESSION; GERIATRIC ASSESSMENT; HUMANS; MALE; MOTIVATION;

EID: 3042729686     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Marin, RS. Apathy: A neuropsychiatric syndrome. J Neuropsychiatry 1991; 3(3): 243-254.
2. Marin, RS. Apathy: Who cares? An introduction to apathy and related disorders of diminished motivation. Psychiatric Ann 1997; 27: 18-23.
3. Rubin EH, Morris JC, Storandt M, et al. Behavioral changes in patients with mild senile dementia of the Alzheimer' type. Psychiatry Res 1987; 21: 55-62.
4. Starkstein SE, Petracc G, Chemerinski E, Kremer J. Syndromic validity of apathy in Alzheimer's disease. Am J Psychiatry 2001; 158(6): 872-877.
5. Starkstein SE, Fedoroff JP, Price TR, Leiguarda, R, Robinson RG. Apathy following cerebrovascular lesions. Stroke 1993; 24(11): 1625-1630.
6. Starkstein SE, Mayberg HS, Preziosi TJ, Andrezewski P, Leiguarda R, Robinson RG. Reliability, validity, and clinical correlates of apathy in Parkinson's disease. J Neuropsych Clin Neurosci 1992; 4(2): 134-139.
7. Krishnan KRR, Hay JC, Blazer DG. MRI-defined vascular depression. Am J Psychiatry 1997; 154: 497-500.
8. Feil D, Razani J, Boone K, Lesser, I. Apathy and cognitive performance in older adults with depression. Intern J Geri Psych 2003; 18: 479-485.
9. Corcoran C, Wong ML, O'Keane V. Buproprion in the management of apathy. J Psychopharm 2004; 18(1): 133-135.
10. Marin RS, Fogel BS, Hawkins J, Duffy, J, Krupp, B. Apathy: a treatable syndrome. J Neuropsych Clin Neurosci 1995; 7(1): 23-30.
11. Drayton, SJ, Davies K, Steinberg M, Leroi, I, Rosenblatt, A, Lyketsos, CG. Amantadine for executive dysfunction syndrome in patients with dementia. Psychosomatics 2004; 45(3): 205-209.
12. Cummings JL. Cholinesterase inhibitors: A new class of psychotropic compounds. Am J Psychiatry 2000; 157(1): 4-15.
13. Grutzner L. Case report. Dementia with apathy. MMW Fortschr Med 2002; 144(31-32): 56.